Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2023

Open Access 01-12-2023 | Duchenne Muscular Dystrophy | Research

Derivation and validation of diagnostic models for myocardial fibrosis in duchenne muscular dystrophy: assessed by multi-parameter cardiovascular magnetic resonance

Authors: Zi-qi Zhou, Hua-yan Xu, Hang Fu, Ke Xu, Rong Xu, Xiao-tang Cai, Ying-kun Guo

Published in: Orphanet Journal of Rare Diseases | Issue 1/2023

Login to get access

Abstract

Background

Gadolinium-enhanced cardiovascular magnetic resonance (CMR) is the most widely used approach for diagnosing myocardial fibrosis with late gadolinium enhancement (LGE) in cardiomyopathy associated with Duchenne muscular dystrophy. Given the limitations and safety of gadolinium use, we wanted to develop and evaluate multi-parametric pre-contrast CMR models for the diagnosis of LGE and investigate whether they could be utilised as surrogates for LGE in DMD patients.

Methods

A total of 136 DMD patients were prospectively recruited and separated into LGE − and LGE + groups. In the first subset of patients (derivation cohort), regression models for the diagnosis of LGE were built by logistic regression using pre-contrast sequence parameters. In a validation cohort of other patients, the models’ performances were evaluated.

Results

EF, native T1 and longitudinal strain alone, as well as their combinations form seven models. The model that included EF, native T1 and longitudinal strain had the best diagnostic value, but there was no significant difference in diagnostic accuracy among the other models except EF. In the validation cohort, the diagnosis outcomes of models were moderate consistent with the existence of LGE. The longitudinal strain outperformed the other models in terms of diagnostic value (sensitivity: 83.33%, specificity: 54.55%).

Conclusions

Pre-contrast sequences have a moderate predictive value for LGE. Thus, pre-contrast parameters may be considered only in a specific subset of DMD patients who cannot cooperate for long-time examinations and have contradiction of contrast agent to help predict the presence of LGE.

Trial registration number (TRN)

ChiCTR1800018340

Date of registration

20180107
Appendix
Available only for authorised users
Literature
2.
go back to reference Villanova M, Brancalion B, Mehta AD. Duchenne muscular dystrophy: life prolongation by noninvasive ventilatory support. Am J Phys Med Rehab. 2014;93:595–9.CrossRef Villanova M, Brancalion B, Mehta AD. Duchenne muscular dystrophy: life prolongation by noninvasive ventilatory support. Am J Phys Med Rehab. 2014;93:595–9.CrossRef
3.
go back to reference Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, et al. DMD Care Considerations Working Group, diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17(3):251–67.CrossRefPubMedPubMedCentral Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, et al. DMD Care Considerations Working Group, diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018;17(3):251–67.CrossRefPubMedPubMedCentral
4.
go back to reference Raman SV, Hor KN, Mazur W, Halnon NJ, Kissel JT, He X, et al. Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2015;14(2):153–61.CrossRefPubMed Raman SV, Hor KN, Mazur W, Halnon NJ, Kissel JT, He X, et al. Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2015;14(2):153–61.CrossRefPubMed
5.
go back to reference Mavrogeni SI, Markousis-Mavrogenis G, Papavasiliou A, Papadopoulos G, Kolovou G. Cardiac involvement in Duchenne muscular dystrophy and related dystrophinopathies. Methods Mol Biol. 2018;1687:31–42.CrossRefPubMed Mavrogeni SI, Markousis-Mavrogenis G, Papavasiliou A, Papadopoulos G, Kolovou G. Cardiac involvement in Duchenne muscular dystrophy and related dystrophinopathies. Methods Mol Biol. 2018;1687:31–42.CrossRefPubMed
6.
go back to reference Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, et al. Cardiac Management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142(Suppl 2):72–81.CrossRef Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, et al. Cardiac Management of the patient with Duchenne muscular dystrophy. Pediatrics. 2018;142(Suppl 2):72–81.CrossRef
7.
go back to reference Silva MC, Meira ZM, Gurgel Giannetti J, da Silva MM, Campos AF, Barbosa Mde M, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol. 2007;49(18):1874–9.CrossRefPubMed Silva MC, Meira ZM, Gurgel Giannetti J, da Silva MM, Campos AF, Barbosa Mde M, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol. 2007;49(18):1874–9.CrossRefPubMed
8.
go back to reference Menon SC, Etheridge SP, Liesemer KN, Williams RV, Bardsley T, Heywood MC, et al. Predictive value of myocardial delayed enhancement in Duchenne muscular dystrophy. Pediatr Cardiol. 2014;35(7):1279–85.CrossRefPubMed Menon SC, Etheridge SP, Liesemer KN, Williams RV, Bardsley T, Heywood MC, et al. Predictive value of myocardial delayed enhancement in Duchenne muscular dystrophy. Pediatr Cardiol. 2014;35(7):1279–85.CrossRefPubMed
10.
go back to reference Florian A, Ludwig A, Engelen M, Waltenberger J, Rösch S, Sechtem U, et al. Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients. J Cardiovasc Magn Reson. 2014;16(1):81.CrossRefPubMedPubMedCentral Florian A, Ludwig A, Engelen M, Waltenberger J, Rösch S, Sechtem U, et al. Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients. J Cardiovasc Magn Reson. 2014;16(1):81.CrossRefPubMedPubMedCentral
11.
go back to reference Walcher T, Steinbach P, Spiess J, Kunze M, Gradinger R, Walcher D, et al. Detection of long-term progression of myocardial fibrosis in Duchenne muscular dystrophy in an affected family: a cardiovascular magnetic resonance study. Eur J Radiol. 2011;80(1):115–9.CrossRefPubMed Walcher T, Steinbach P, Spiess J, Kunze M, Gradinger R, Walcher D, et al. Detection of long-term progression of myocardial fibrosis in Duchenne muscular dystrophy in an affected family: a cardiovascular magnetic resonance study. Eur J Radiol. 2011;80(1):115–9.CrossRefPubMed
13.
go back to reference McDonald JS, Hunt CH, Kolbe AB, Schmitz JJ, Hartman RP, Maddox DE, et al. Acute adverse events following gadolinium-based contrast Agent Administration: a Single-Center Retrospective Study of 281945 injections. Radiology. 2019;292(3):620–7.CrossRefPubMed McDonald JS, Hunt CH, Kolbe AB, Schmitz JJ, Hartman RP, Maddox DE, et al. Acute adverse events following gadolinium-based contrast Agent Administration: a Single-Center Retrospective Study of 281945 injections. Radiology. 2019;292(3):620–7.CrossRefPubMed
14.
go back to reference Samson K. FDA investigating risk of Brain deposits of Gadolinium MRI contrast agents. Neurol Today. 2015;15:25–6.CrossRef Samson K. FDA investigating risk of Brain deposits of Gadolinium MRI contrast agents. Neurol Today. 2015;15:25–6.CrossRef
15.
go back to reference Tibussek D, Caspers CRJ, Turowski B, Schaper J, Antoch G, Klee D. Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study. Radiology. 2017;285:223–30.CrossRefPubMed Tibussek D, Caspers CRJ, Turowski B, Schaper J, Antoch G, Klee D. Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study. Radiology. 2017;285:223–30.CrossRefPubMed
16.
go back to reference Erley J, Genovese D, Tapaskar N, Alvi N, Rashedi N, Besser SA, et al. Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement. J Cardiovasc Magn Reson. 2019;21(1):46.CrossRefPubMedPubMedCentral Erley J, Genovese D, Tapaskar N, Alvi N, Rashedi N, Besser SA, et al. Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement. J Cardiovasc Magn Reson. 2019;21(1):46.CrossRefPubMedPubMedCentral
17.
go back to reference Xu K, Xu HY, Xu R, Xie LJ, Yang ZG, Yu L, et al. Global, segmental and layer specific analysis of myocardial involvement in Duchenne muscular dystrophy by cardiovascular magnetic resonance native T1 mapping. J Cardiovasc Magn Reson. 2021;23(1):110.CrossRefPubMedPubMedCentral Xu K, Xu HY, Xu R, Xie LJ, Yang ZG, Yu L, et al. Global, segmental and layer specific analysis of myocardial involvement in Duchenne muscular dystrophy by cardiovascular magnetic resonance native T1 mapping. J Cardiovasc Magn Reson. 2021;23(1):110.CrossRefPubMedPubMedCentral
18.
go back to reference Raucci FJ Jr, Xu M, George-Durrett K, Crum K, Slaughter JC, Parra DA, et al. Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy. J Cardiovasc Magn Reson. 2021;23(1):48.CrossRefPubMedPubMedCentral Raucci FJ Jr, Xu M, George-Durrett K, Crum K, Slaughter JC, Parra DA, et al. Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy. J Cardiovasc Magn Reson. 2021;23(1):48.CrossRefPubMedPubMedCentral
19.
go back to reference Xue H, Shah S, Greiser A, Guetter C, Littmann A, Jolly MP, et al. Motion correction for myocardial T1 mapping using image registration with synthetic image estimation. Magn Reson Med. 2012;67(6):1644–55.CrossRefPubMed Xue H, Shah S, Greiser A, Guetter C, Littmann A, Jolly MP, et al. Motion correction for myocardial T1 mapping using image registration with synthetic image estimation. Magn Reson Med. 2012;67(6):1644–55.CrossRefPubMed
20.
go back to reference Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular magnetic resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson. 2013;15(1):35.CrossRefPubMedPubMedCentral Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular magnetic resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson. 2013;15(1):35.CrossRefPubMedPubMedCentral
21.
go back to reference Schlett CL, Lorbeer R, Arndt C, Auweter S, Machann J, Hetterich H, et al. Association between abdominal adiposity and subclinical measures of left-ventricular remodeling in diabetics, prediabetics and normal controls without history of cardiovascular disease as measured by magnetic resonance imaging: results from the KORA-FF4 study. Cardiovasc Diabetol. 2018;17(1):88–99.CrossRefPubMedPubMedCentral Schlett CL, Lorbeer R, Arndt C, Auweter S, Machann J, Hetterich H, et al. Association between abdominal adiposity and subclinical measures of left-ventricular remodeling in diabetics, prediabetics and normal controls without history of cardiovascular disease as measured by magnetic resonance imaging: results from the KORA-FF4 study. Cardiovasc Diabetol. 2018;17(1):88–99.CrossRefPubMedPubMedCentral
22.
go back to reference Riffel JH, Keller MG, Rost F, Arenja N, Andre F, Aus dem Siepen F, et al. Left ventricular long axis strain: a new prognosticator in non-ischemic dilated cardiomyopathy? J Cardiovasc Magn Reson. 2016;18(1):36.CrossRefPubMedPubMedCentral Riffel JH, Keller MG, Rost F, Arenja N, Andre F, Aus dem Siepen F, et al. Left ventricular long axis strain: a new prognosticator in non-ischemic dilated cardiomyopathy? J Cardiovasc Magn Reson. 2016;18(1):36.CrossRefPubMedPubMedCentral
23.
go back to reference Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular magnetic resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15(1):92.CrossRefPubMedPubMedCentral Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular magnetic resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15(1):92.CrossRefPubMedPubMedCentral
24.
go back to reference Frankel KA, Rosser RJ. The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Hum Pathol. 1976;7:375–86.CrossRefPubMed Frankel KA, Rosser RJ. The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Hum Pathol. 1976;7:375–86.CrossRefPubMed
25.
go back to reference Maforo NG, Magrath P, Moulin K, Shao J, Kim GH, Prosper A, et al. T1-Mapping and extracellular volume estimates in pediatric subjects with Duchenne muscular dystrophy and healthy controls at 3T. J Cardiovasc Magn Reson. 2020;22(1):85.CrossRefPubMedPubMedCentral Maforo NG, Magrath P, Moulin K, Shao J, Kim GH, Prosper A, et al. T1-Mapping and extracellular volume estimates in pediatric subjects with Duchenne muscular dystrophy and healthy controls at 3T. J Cardiovasc Magn Reson. 2020;22(1):85.CrossRefPubMedPubMedCentral
26.
go back to reference Olivieri LJ, Kellman P, Mccarter RJ, Cross RR, Hansen MS, Spurney CF. Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystrophy. J Cardiovasc Magn Reson. 2017;18:72.CrossRef Olivieri LJ, Kellman P, Mccarter RJ, Cross RR, Hansen MS, Spurney CF. Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystrophy. J Cardiovasc Magn Reson. 2017;18:72.CrossRef
27.
go back to reference Yilmaz A, Gdynia HJ, Baccouche H, Mahrholdt H, Meinhardt G, Basso C, et al. Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson. 2008;10(1):50.CrossRefPubMedPubMedCentral Yilmaz A, Gdynia HJ, Baccouche H, Mahrholdt H, Meinhardt G, Basso C, et al. Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson. 2008;10(1):50.CrossRefPubMedPubMedCentral
28.
go back to reference Johnston JH, Kim HK, Merrow AC, Laor T, Serai S, Horn PS, et al. Quantitative skeletal muscle MRI: part 1, derived T2 Fat Map in differentiation between boys with Duchenne muscular dystrophy and healthy boys. AJR Am J Roentgenol. 2015;205(2):207–15.CrossRef Johnston JH, Kim HK, Merrow AC, Laor T, Serai S, Horn PS, et al. Quantitative skeletal muscle MRI: part 1, derived T2 Fat Map in differentiation between boys with Duchenne muscular dystrophy and healthy boys. AJR Am J Roentgenol. 2015;205(2):207–15.CrossRef
29.
go back to reference Huang Y, Majumdar S, Genant HK, Chan WP, Sharma KR, Yu P, et al. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J Magn Reson Imaging. 1994;4(1):59–64.CrossRefPubMed Huang Y, Majumdar S, Genant HK, Chan WP, Sharma KR, Yu P, et al. Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J Magn Reson Imaging. 1994;4(1):59–64.CrossRefPubMed
30.
go back to reference Ghaleh B, Barthélemy I, Sambin L, Bizé A, Hittinger L, Blot S, et al. Alteration in left ventricular contractile function develops in Puppies with Duchenne muscular dystrophy. J Am Soc Echocardiogr. 2020;33(1):120–9.CrossRefPubMed Ghaleh B, Barthélemy I, Sambin L, Bizé A, Hittinger L, Blot S, et al. Alteration in left ventricular contractile function develops in Puppies with Duchenne muscular dystrophy. J Am Soc Echocardiogr. 2020;33(1):120–9.CrossRefPubMed
31.
go back to reference Mertens L, Ganame J, Claus P, Goemans N, Thijs D, Eyskens B, et al. Early regional myocardial dysfunction in young patients with Duchenne muscular dystrophy. J Am Soc Echocardiogr. 2008;21(9):1049–54.CrossRefPubMed Mertens L, Ganame J, Claus P, Goemans N, Thijs D, Eyskens B, et al. Early regional myocardial dysfunction in young patients with Duchenne muscular dystrophy. J Am Soc Echocardiogr. 2008;21(9):1049–54.CrossRefPubMed
32.
go back to reference Lang SM, Alsaied T, Khoury PR, Ryan TD, Taylor MD. Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement. Int J Cardiovas Imag. 2021;37:635–42.CrossRef Lang SM, Alsaied T, Khoury PR, Ryan TD, Taylor MD. Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement. Int J Cardiovas Imag. 2021;37:635–42.CrossRef
33.
go back to reference Nunes MF, Hukuda ME, Favero FM, Oliveira AB, Voos MC, Caromano FA. Relationship between muscle strength and motor function in Duchenne muscular dystrophy. Arq Neuropsiquiatr. 2016;74:530–5.CrossRefPubMed Nunes MF, Hukuda ME, Favero FM, Oliveira AB, Voos MC, Caromano FA. Relationship between muscle strength and motor function in Duchenne muscular dystrophy. Arq Neuropsiquiatr. 2016;74:530–5.CrossRefPubMed
34.
go back to reference Luiz LC, Marson FAL, Almeida CCB, Contrera Toro AAD, Nucci A, Ribeiro JD. Analysis of motor and respiratory function in Duchenne muscular dystrophy patients. Resp Physiol Neurobi. 2019;262:1–11.CrossRef Luiz LC, Marson FAL, Almeida CCB, Contrera Toro AAD, Nucci A, Ribeiro JD. Analysis of motor and respiratory function in Duchenne muscular dystrophy patients. Resp Physiol Neurobi. 2019;262:1–11.CrossRef
36.
go back to reference Bilchick KC, Salerno M, Plitt D, Dori Y, Crawford TO, Drachman D, et al. Prevalence and distribution of regional scar in dysfunctional myocardial segments in Duchenne muscular dystrophy. J Cardiovasc Magn Reson. 2011;13(1):20.CrossRefPubMedPubMedCentral Bilchick KC, Salerno M, Plitt D, Dori Y, Crawford TO, Drachman D, et al. Prevalence and distribution of regional scar in dysfunctional myocardial segments in Duchenne muscular dystrophy. J Cardiovasc Magn Reson. 2011;13(1):20.CrossRefPubMedPubMedCentral
Metadata
Title
Derivation and validation of diagnostic models for myocardial fibrosis in duchenne muscular dystrophy: assessed by multi-parameter cardiovascular magnetic resonance
Authors
Zi-qi Zhou
Hua-yan Xu
Hang Fu
Ke Xu
Rong Xu
Xiao-tang Cai
Ying-kun Guo
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2023
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-023-02931-y

Other articles of this Issue 1/2023

Orphanet Journal of Rare Diseases 1/2023 Go to the issue